NLS Pharmaceutics : UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS - Form 6-K -December 06, 2023 at 04:49 pm EST
UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS Page ...
Source: marketscreener.com
Stay updated with breaking news from Chad Hellmann. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS Page ...
ZÜRICH, SWITZERLAND / ACCESSWIRE / May 8, 2023 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company focused on the discovery and
Investegate announcements from NLS Pharmaceutics AG, NLS Pharmaceutics Issues Letter to Shareholders
ZURICH, SWITZERELAND / ACCESSWIRE / December 22, 2022 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage biopharmaceutical company, focused on the discovery